Diaceutics (LON:DXRX) Stock Price Down 0.7% – Should You Sell?

Diaceutics PLC (LON:DXRX) dropped 0.7% during mid-day trading on Thursday . The company traded as low as GBX 144.52 and last traded at GBX 144.55. Approximately 31,072 shares were traded during mid-day trading, a decline of 78% from the average daily volume of 143,706 shares. The stock had previously closed at GBX 145.50.

Wall Street Analyst Weigh In

Separately, Shore Capital Group upped their target price on Diaceutics from GBX 180 to GBX 215 and gave the stock a “buy” rating in a report on Thursday, January 15th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus price target of GBX 193.33.

Diaceutics Stock Down 0.7%

The company’s fifty day simple moving average is GBX 156.03 and its 200-day simple moving average is GBX 152.45. The company has a debt-to-equity ratio of 3.05, a current ratio of 3.96 and a quick ratio of 9.92. The firm has a market capitalization of £122.33 million, a PE ratio of -80.31 and a beta of 0.58.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.